Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07272720

PMCF Investigation of MODULITH® SLX-F2 With StorM-Track in Patients With Kidney Stones

Post-Market Clinical Follow-Up Investigation of MODULITH® SLX-F2 With StorM-Track in Patients With Kidney Stones - A Confirmatory Parallel-Group, Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
126 (estimated)
Sponsor
Storz Medical AG · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Extracorporeal shockwave lithotripsy (ESWL) is a non-invasive standard treatment for kidney stones. This study will be conducted to evaluate the effectiveness of ESWL using MODULITH® SLX-F2 with stone tracking, compared to MODULITH® SLX-F2 without stone tracking, in adult patients with kidney stones, as measured by stone-free status.

Detailed description

The success of ESWL depends on multiple procedure- and patient-specific factors, one crucial factor being accurate stone targeting. Respiration induced kidney movement affects stone targeting as it results in the stone not being hit by the shock waves for up to 50% of the treatment time. To improve the accuracy of stone targeting and comminution, an additional tracking module has been incorporated into the state-of-the-art lithotripter MODULITH® SLX-F2. The device is CE marked including its tracking module. The scientific rationale for conducting this clinical investigation is based on the hypothesis that improved stone targeting through real-time tracking may lead to increased treatment efficacy and safety, as reflected by higher stone-free rates, reduced need for re-treatment, an increased quality of life, and lower adverse events rates.

Conditions

Interventions

TypeNameDescription
DEVICEESWL with kidney stone tracking (StorM-Track)Starting ESWL on a low energy setting with stepwise ramping and at a frequency of 1.0 or 1.5 Hz. Up to a maximum of 3'500 shockwaves unless there is no stone visible in X-ray imaging. If fragments \> 4mm remain after the first ESWL treatment, a 2nd ESWL will be performed.
DEVICEStandard ESWL without stone tracking (StorM-Track disabled)Same treatment protocol as for the intervention group. If fragments \> 4mm remain after the first ESWL treatment, a 2nd ESWL will be performed.

Timeline

Start date
2025-12-11
Primary completion
2026-09-01
Completion
2027-07-01
First posted
2025-12-09
Last updated
2025-12-18

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT07272720. Inclusion in this directory is not an endorsement.